Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-06-22 5:20 pm Purchase | 13D | STREAMLINE HEALTH SOLUTIONS, I STRM | Tamarack Advisers LP | 5,514,515 9.4% | 386,207 (+7.53%) | View |
| 2022-11-30 8:19 pm Purchase | 13D | STREAMLINE HEALTH SOLUTIONS, I STRM | Tamarack Advisers LP | 5,128,308 10.7% | 92,245 (+1.83%) | View |
| 2021-03-22 7:51 pm Purchase | 13D | STREAMLINE HEALTH SOLUTIONS, I STRM | Tamarack Advisers LP | 5,036,063 12.1% | 693,929 (+15.98%) | View |
| 2021-02-12 6:02 pm Sale | 13G | IVERIC BIO INC ISEE | Tamarack Advisers LP | 850,000 0.1% | -1,800,000 (-67.92%) | View |
| 2020-02-14 1:03 pm Sale | 13G | OBALON THERAPEUTICS INC OBLN | Tamarack Advisers LP | 0 0% | -2,100,000 (Position Closed) | View |
| 2020-02-13 9:39 pm Purchase | 13G | CORREVIO PHARMA CORP COM CORV | Tamarack Advisers LP | 2,500,000 4.9% | 375,000 (+17.65%) | View |
| 2020-02-13 9:37 pm Purchase | 13G | IVERIC BIO INC ISEE | Tamarack Advisers LP | 2,650,000 5.5% | 2,650,000 (New Position) | View |
| 2019-12-13 5:07 pm Unchanged | 13D | STREAMLINE HEALTH SOLUTIONS, I STRM | Tamarack Advisers LP | 4,342,134 14.2% | 0 (Unchanged) | View |
| 2019-11-08 4:43 pm Purchase | 13G | STREAMLINE HEALTH SOLUTIONS, I STRM | Tamarack Advisers LP | 4,342,134 14.2% | 2,392,134 (+122.67%) | View |